ES2185146T3 - Receptores de netrina. - Google Patents

Receptores de netrina.

Info

Publication number
ES2185146T3
ES2185146T3 ES98906547T ES98906547T ES2185146T3 ES 2185146 T3 ES2185146 T3 ES 2185146T3 ES 98906547 T ES98906547 T ES 98906547T ES 98906547 T ES98906547 T ES 98906547T ES 2185146 T3 ES2185146 T3 ES 2185146T3
Authority
ES
Spain
Prior art keywords
unc
proteins
vertebrate
relates
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98906547T
Other languages
English (en)
Inventor
Marc Tessier-Lavigne
E David Leonardo
Lindsay Hinck
Masayuki Masu
Keino-Masu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Application granted granted Critical
Publication of ES2185146T3 publication Critical patent/ES2185146T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a procedimientos y a composiciones de proteínas UNC-5 de vertebrados, que funciona como proteínas receptoras de las netrinas, una familia de proteínas de regulación celular. Estas proteínas pueden ser producidas por recombinación a partir de células huésped transformadas a partir de dicha UNC-5 que codifica un ácido nucléico, o purificadas a partir de células humanas. La invención se refiere también a sondas y a cebos de hibridación, capaces de hibridarse específicamente con el gen unc-5 de vertebrados de la presente invención. La invención se refiere finalmente a agentes de enlace específicos de la UNC-5 de vertebrados como anticuerpos específicos, aí como a procedimientos de fabricación y de utilización de dichas composiciones en el diagnóstico, la terapia y la industria biofarmacéutica.
ES98906547T 1997-02-19 1998-02-19 Receptores de netrina. Expired - Lifetime ES2185146T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/808,982 US5939271A (en) 1997-02-19 1997-02-19 Netrin receptor

Publications (1)

Publication Number Publication Date
ES2185146T3 true ES2185146T3 (es) 2003-04-16

Family

ID=25200268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98906547T Expired - Lifetime ES2185146T3 (es) 1997-02-19 1998-02-19 Receptores de netrina.

Country Status (11)

Country Link
US (6) US5939271A (es)
EP (1) EP0973794B1 (es)
JP (2) JP2001505062A (es)
AT (1) ATE226216T1 (es)
AU (1) AU718795B2 (es)
CA (1) CA2280290C (es)
DE (1) DE69808743T2 (es)
DK (1) DK0973794T3 (es)
ES (1) ES2185146T3 (es)
PT (1) PT973794E (es)
WO (1) WO1998037085A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6350583B1 (en) * 1997-09-09 2002-02-26 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
ES2322859T3 (es) * 1998-05-01 2009-06-30 Gen-Probe Incorporated Analizador de diagnostico automatizado.
AU3667600A (en) * 1999-03-10 2000-09-28 Mcgill University Methods for identifying compounds that modulate synaptic plasticity and cell motility
GB9912755D0 (en) * 1999-06-01 1999-08-04 Devgen Nv UNC-5 constructs and screening methods
US6600018B1 (en) 2000-04-10 2003-07-29 The United States Of America As Represented By The Department Of Health And Human Services Secreted frizzled related protein, sFRP, fragments and methods of use thereof
US6465632B1 (en) * 2000-06-09 2002-10-15 Lexicon Genetics Incorporated Human phosphatases and polynucleotides encoding the same
CA2414015A1 (en) * 2000-06-21 2001-12-27 Incyte Genomics, Inc. Human receptors
US20030064369A1 (en) * 2000-07-28 2003-04-03 Taupier Raymond J. Novel proteins and nucleic acids encoding same
CA2423677A1 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
AU2001293870A1 (en) * 2000-10-16 2002-04-29 Bayer Aktiengesellschaft Regulation of human netrin binding membrane receptor unc5h-1
WO2002057450A2 (en) * 2000-11-29 2002-07-25 Curagen Corporation Proteins and nucleic acids encoding same
WO2002055547A2 (en) * 2001-01-10 2002-07-18 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services Sfrp and peptide motifs that interact with sfrp and methods of their use
US7109000B2 (en) 2001-03-08 2006-09-19 Curagen Corporation Proteins and nucleic acids encoding same
JP3746497B2 (ja) 2003-06-24 2006-02-15 松下電器産業株式会社 フォトマスク
US20060025335A1 (en) * 2004-01-30 2006-02-02 Kinane Thomas B Netrin compositions and methods of using the same
CA2573720A1 (en) * 2004-07-14 2006-02-23 University Of Utah Research Foundation Netrin-related compositions and uses
JP5602368B2 (ja) 2006-02-28 2014-10-08 サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） ネトリン−１活性を用いた抗癌化合物のスクリーニング
AR074369A1 (es) * 2008-11-20 2011-01-12 Genentech Inc Anticuerpos anti-unc 5b (receptor de netrina) y metodos de uso
PE20180251A1 (es) 2015-04-28 2018-02-02 Mitsubishi Tanabe Pharma Corp PROTEINA DE UNIION A RGMa Y SU USO

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3665893A (en) * 1992-02-12 1993-09-03 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The Sequences characteristic of human gene transcription product
US5747262A (en) * 1995-10-16 1998-05-05 The Regents Of The University Of California Neurological drug screens

Also Published As

Publication number Publication date
AU718795B2 (en) 2000-04-20
DK0973794T3 (da) 2002-11-11
JP2004121244A (ja) 2004-04-22
US20060147988A1 (en) 2006-07-06
EP0973794A1 (en) 2000-01-26
US20080241857A1 (en) 2008-10-02
EP0973794B1 (en) 2002-10-16
CA2280290A1 (en) 1998-08-27
AU6174498A (en) 1998-09-09
US20030040046A1 (en) 2003-02-27
US6277585B1 (en) 2001-08-21
US7919588B2 (en) 2011-04-05
PT973794E (pt) 2003-03-31
US5939271A (en) 1999-08-17
JP4387735B2 (ja) 2009-12-24
WO1998037085A1 (en) 1998-08-27
ATE226216T1 (de) 2002-11-15
CA2280290C (en) 2003-10-07
EP0973794A4 (en) 2000-12-06
DE69808743D1 (en) 2002-11-21
DE69808743T2 (de) 2003-07-24
US7041806B2 (en) 2006-05-09
JP2001505062A (ja) 2001-04-17
US20030059859A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
BRPI0612273B8 (pt) anticorpo de ligação a il-1 beta ou fragmento de ligação a il-1 beta do mesmo, ácido nucleico, vetor, e, composição
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
EP0973794A4 (en) NETRIN RECEPTORS
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DK1337629T3 (da) Dipeptidylpeptidaser
BRPI0516572A (pt) métodos e composições para melhorar a produção de proteìnas recombinantes
CA2079454A1 (en) Steroid 5.alpha.-reductases
ATE284383T1 (de) Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen
WO2002006457A3 (en) Novel lipase genes
DE3382789D1 (de) Tierische Interferone, Verfahren bei deren Herstellung, dieselben enthaltende Zusammensetzungen, kodierende DNS-Sequenzen hierfür und diese Sequenzen enthaltende Expressionsvektoren und dadurch transformierte Zellen.
ATE384787T1 (de) Tripeptidyl-aminopeptidase
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
WO1998011232A3 (en) Human nm23-like protein
WO1995011919A3 (de) REKOMBINANTE PilC-PROTEINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG
WO2002090524A3 (en) Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
Pease et al. Mapping class I gene sequences in the major histocompatibility complex
DE69728897D1 (de) Saeugetierchemokine
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
BRPI0409948A (pt) composições de spex e processos de uso
ES2169995A1 (es) Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
ATE399794T1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
Zelnick et al. A composite transposon 3′ to the cow fetal globin gene binds a sequence specific factor
WO2000047723A3 (en) Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
MXPA02004825A (es) Genes especificamente expresados en celulas dendriticas humanas.